Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |
Sk. Meharunnisa*, P. Vasanthi, M. Pallavi, R. Divya Sri, Y. Niharika Reddy, Dr. M. Prapurna Chandra
Department of Pharmacy Practice, Ratnam Institute of Pharmacy, Pidathapolur, Nellore, A.P, India
DOI: https://doi.org/10.30904/j.ijmpr.2024.4640
Int. J. Med. Pharm. Res., 2024, 12(1): 12-16
A B S T R A C T
The respiratory system is the network of organs and tissues that help you breathe. It includes the airway, lungs, and blood vessels. it is divided into upper respiratory tract(URT) and lower respiratory tract(LRT). lower respiratory tract infections tend to last longer and can be more serious when compared to URTIs. Pneumonia is the most common LRTI that affects the alveoli and distal airway, this is the fourth leading cause of death. Pneumonia occurs more commonly in susceptible individuals, including children of < 5 years of age and older adults with >60 years of age. A large variety of microorganisms can cause pneumonia including bacteria, viruses, and fungi. Laboratory tests are used to assess and treat. antibiotics are the primary treatment for pneumonia. Antibiotics like Azithromycin and amoxicillin are frequently utilized. As a result of long-term antibiotic use, adults frequently develop resistance. In this study, we analyzed the patient data and identified antibiotic therapy and its differential complications among adults and children are also included. We educate the patients about antibiotics and antibiotic-related complications in adult vs paediatric pneumonia patients.
Keywords: Bacterial pneumonia, lower respiratory tract infection, antibiotics, staphylococcus pneumonia, curb-65, procalcitonin, antibiotic resistance.
